CRISPR Therapeutics AG Market Cap

CRISPR Therapeutics AG has a market cap or net worth of 3.25 billion as of February 21, 2025. Its market cap has decreased by -22.98% in one year.

Market Cap

3.25B

Enterprise Value

1.92B

Revenue

29.81M

Ranking

n/a

PE Ratio

n/a

Stock Price

47.47

Market Cap Chart

Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from 451.35M to 3.25B, an increase of 620.24%. That is a compound annual growth rate of 26.68%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	3.25B	21.14%
Dec 31, 2024	2.68B	-31.26%
Dec 29, 2023	3.90B	47.79%
Dec 30, 2022	2.64B	-38.32%
Dec 31, 2021	4.28B	-45.95%
Dec 31, 2020	7.92B	189.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.71B
Shell	164.13B
HSBC Holdings	156.44B
Unilever	110.21B
Rio Tinto Group	85.92B
RELX PLC	73.75B
BP p.l.c.	70.76B
British American Tobacco p.l.c.	66.72B

Market Cap Rankings